PhRMA CEO Stephen Ubl at #JPM23 (Adrien Villez for Endpoints News)

PhRMA calls doc­u­ment de­struc­tion part of new guid­ance on drug price ne­go­ti­a­tions 'un­con­sti­tu­tion­al'

Many have won­dered how the bio­phar­ma in­dus­try might take CMS to court over its new drug price ne­go­ti­a­tions plans, and lob­by­ing group PhRMA of­fered a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.